Immunotherapy in high-risk pediatric sarcomas shows promisin...(oducing a strong and sustained immune re...)
Navigation Links
Immunotherapy in high-risk pediatric sarcomas shows promising response
Date:7/31/2008
oducing a strong and sustained immune response to tumor antigens," she said.
Mackall also notes that the vaccine in this trial was tested in patients whose cancer had recurred or metastasized. If the favorable safety profile continues and the efficacy of the vaccine is improved with the subsequent versions, one could ultimately consider the use of immunotherapy to consolidate remission in lower risk populations.
'/>"/>
| Contact: Jeremy Moore Jeremy.moore@aacr.org 267-646-0557 American Association for Cancer Research Source:Eurekalert |
Related biology news :
1. Cancer immunotherapy shows long-term promise in lung cancer
2. Leading pediatrician addresses the future of childrens health
3. Pediatricians alerted to the developmental nature of underage drinking in special journal supplement
4. Research shows skeleton to be endocrine organ
5. Clones on task serve greater good, evolutionary study shows
6. Study shows link between alcohol consumption and hiv disease progression
7. Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
8. New study shows greenback cutthroat trout involved in recovery effort misidentified
9. DNA analysis shows true dispersal of protozoa
10. New genetic research into nicotine addiction shows promise for personalized treatment
11. International team shows mercury concentrations in fish respond quickly to increased deposition
Post Your Comments:
Breaking Biology News(10 mins):Type 2 diabetes gene predisposes children to obesity 2Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences 2New understanding of how to prevent destruction of a tumor suppressor 2While you were sleeping 47771 1While you were sleeping 47771 2Women may not be so picky after all about choosing a mate 47768 1Women may not be so picky after all about choosing a mate 47768 2Women may not be so picky after all about choosing a mate 47768 3Too Many Bouncers Make Trampolines More Dangerous 47766 1
Other Biology News:Scientist measures role of science's coolest player: The snow 2Stress substantially slows human body's ability to heal 2Stress substantially slows human body's ability to heal 3
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2
[0] Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe[0] Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock[0] Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators[0] Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures
Other Biology Technology:ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 2ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 3ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference 4US Oncology Provides Full Service Management of Clinical Trials 2US Oncology Provides Full Service Management of Clinical Trials 3Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |